These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16018598)

  • 21. Combined-modality treatment for operable pancreatic adenocarcinoma.
    Pisters PW; Wolff RA; Crane CH; Evans DB
    Oncology (Williston Park); 2005 Mar; 19(3):393-404, 409; discussion 409-10, 412-6. PubMed ID: 15828554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The value of extended surgery for pancreatic cancer in the context of neoadjuvant therapy].
    Zhang TP; Liu YZ; Cao Z
    Zhonghua Wai Ke Za Zhi; 2020 Jul; 58(7):481-485. PubMed ID: 32610414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of adjuvant surgery in initially unresectable pancreatic cancer after long-term chemotherapy or chemoradiation therapy: survival benefit?
    Opendro SS; Satoi S; Yanagimoto H; Yamamoto T; Toyokawa H; Hirooka S; Yamaki S; Inoue K; Matsui Y; Kwon AH
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):695-702. PubMed ID: 24841048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of exocrine pancreas tumors].
    Baumel H; Huguier M; Fabre JM; Houry S; Domergue J
    Ann Chir; 1991; 45(3):253-8. PubMed ID: 2042920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to define and manage borderline resectable pancreatic cancer.
    Papavasiliou P; Chun YS; Hoffman JP
    Surg Clin North Am; 2013 Jun; 93(3):663-74. PubMed ID: 23632151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Operability of pancreatic carcinoma, surgical experience].
    Sápy P; Olvasztó S; Pálffy A; Garami Z; Péter M
    Orv Hetil; 1991 Nov; 132(45):2479-82, 2485-6. PubMed ID: 1945392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New developments in the management of borderline resectable pancreatic cancers.
    Goodman MD; McPartland S; Huber K; Saif MW
    JOP; 2013 Jul; 14(4):334-6. PubMed ID: 23846921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II study of neoadjuvant and adjuvant chemotherapy with 5-fluorodeoxyuridine, leucovorin, oxaliplatin and docetaxel in the treatment of previously untreated advanced esophageal adenocarcinoma.
    Solomon N; Mezentsev D; Reis I; Lima M; Rios J; Avisar E; Franceschi D; Livingstone A; Podolsky L; Ardalan B
    Jpn J Clin Oncol; 2011 Apr; 41(4):469-76. PubMed ID: 21258083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical results on intra-arterial adjuvant chemotherapy for prevention of liver metastasis following curative resection of pancreatic cancer.
    Hayashibe A; Kameyama M; Shinbo M; Makimoto S
    Ann Surg Oncol; 2007 Jan; 14(1):190-4. PubMed ID: 17066232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma.
    Artinyan A; Anaya DA; McKenzie S; Ellenhorn JD; Kim J
    Cancer; 2011 May; 117(10):2044-9. PubMed ID: 21523715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A neoadjuvant strategy for the management of nonmetastatic pancreatic cancer.
    Goff SL; Chabot JA
    Cancer J; 2012; 18(6):602-8. PubMed ID: 23187848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
    Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
    Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical approach to pancreatic exocrine neoplasms.
    Wargo JA; Warshaw AL
    Minerva Chir; 2005 Dec; 60(6):445-68. PubMed ID: 16401999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multimodal treatment of pancreatic cancer].
    Shalimov SA; Keĭsevich LV; Zakharov IB; Nichitaĭlo ME; Stasenko AA; Litvinenko AN; Vesnenko AI; Shalev VG
    Klin Khir (1962); 1991; (5):1-3. PubMed ID: 1714983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
    Golcher H; Brunner T; Grabenbauer G; Merkel S; Papadopoulos T; Hohenberger W; Meyer T
    Eur J Surg Oncol; 2008 Jul; 34(7):756-64. PubMed ID: 18191528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hope and frustration of neoadjuvant chemotherapy for resectable pancreatic cancer].
    Lu C; Miao Y; Gao WT
    Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):813-816. PubMed ID: 30392300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pancreatic cancer - current effective diagnostic and therapeutic approach].
    Ryska M
    Cas Lek Cesk; 2016; 155(1):38-43. PubMed ID: 26898790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ASO Author Reflection: Adjuvant Chemotherapy After Neoadjuvant Chemotherapy in Pancreatic Adenocarcinoma Does Not Lead to Improved Survival in All Patients.
    Olecki EJ; Gusani NJ
    Ann Surg Oncol; 2021 Jun; 28(6):3123. PubMed ID: 33616769
    [No Abstract]   [Full Text] [Related]  

  • 40. Surgical management of early-stage pancreatic cancer.
    Zervos EE; Rosemurgy AS; Al-Saif O; Durkin AJ
    Cancer Control; 2004; 11(1):23-31. PubMed ID: 14749620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.